- In June 2024, RevelAi Health and Zimmer Biomet, a prominent MedTech company, entered into a multi-year co-marketing agreement aimed at commercializing generative artificial intelligence (AI)-driven engagement solutions to enhance value-based orthopedic care and promote health equity. As part of this collaboration, Zimmer Biomet intends to introduce RevelAi Health's care team dashboard and patient care management platform to the market. This partnership underscores the commitment of both companies to leverage innovative technology in improving patient outcomes and healthcare accessibility
- In July 2024, Stryker, a leader in medical technology innovation, finalized its acquisition of Artelon, Inc., a privately-owned company known for its expertise in soft tissue products designed primarily for foot and ankle as well as sports medicine procedures. This strategic acquisition aims to strengthen Stryker's product portfolio and enhance its capabilities in delivering advanced solutions for orthopedic care. By integrating Artelon’s offerings, Stryker is poised to better address the needs of healthcare providers and patients in these specialized fields
- In July 2024, Orthofix Medical Inc. obtained FDA clearance for its innovative Fitbone Transport and Lengthening System, a groundbreaking implant designed to address leg bone defects. This system stands out as it can lengthen or repair bone in a single surgical procedure, contrasting with conventional techniques that typically necessitate multiple surgeries. With this advancement, Orthofix aims to improve surgical outcomes and reduce recovery time for patients with leg bone issues
Frequently Asked Questions
The market is segmented based on Segmentation, By Procedures (Joint Replacement and Fractures, and Nerve diseases and Soft Tissue Injuries), Surgical Site (Hand and Wrist, Shoulder, and Arm and Elbow), End User (Hospital, Homecare, and Diagnostic Laboratory), Device Type (Internal Fixators and External Fixators) – Industry Trends And Forecast to 2032
.
The Global Upper Extremities Trauma Devices Market size was valued at USD 1.35 USD Billion in 2024.
The Global Upper Extremities Trauma Devices Market is projected to grow at a CAGR of 9.5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
